Enter your login e-mail to the account
Search
Search parameters
Search results
- Současnost a perspektivy léčby dyslipidémií
doc. MUDr. Jan Bultas, CSc., MUDr. Debora Karetová
(1/2004, Main topic ) - The role of fibrates in a statin world
MUDr. Ľubomíra Fábryová, PhD.
(11/2009, Topic of the year ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - The Importance of Omega – 3 Fatty Acids in the Treatment of Dyslipidemia
prof. MUDr. Daniel Pella, PhD.
(12/2009, Topic of the year ) - MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME
prof. MUDr. Daniel Pella, PhD., doc. MUDr. Viola Mechírová, CSc.
(S4/2007, Supplement ) - XV. medzinárodné sympózium – Drugs Affecting Lipid Metabolism – DALM
MUDr. Ľubomíra Fábryová
(1/2005, Spectrum ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Fixed-dose combinations of calcium channel blockers and angiotensin-converting enzyme inhibitors in hypertension
MUDr. Slavomír Šuch
(3/2010, Drugs & drug classes ) - Dyslipidemia and diabetic foot syndrome
doc. MUDr. David Karásek, Ph.D., MUDr. Daniela Číhalíková
(2/2020, Review articles ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - Drug-induced myopathy with cholesterol-lowering and triacylglycerol-lowering agents
doc. MUDr. Peter Špalek, CSc., MUDr. Denis Richter
(1/2010, Interdisciplinary consilium ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - Treatment of hypertension with a fixed combination. New evidence.
prof. MUDr. Miroslav Souček, CSc.
(10/2009, Review articles ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year ) - OPTIMAL (TARGET) DOSING OF ACE INHIBITORS
doc. MUDr. Jana Sirotiaková, PhD., PhD., Peter Minárik
(12/2008, clearly )
- Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- Homozygous familial hypercholesterolemia and its treatment, cholesterol screening in children in Slovakia
MUDr. Pavol Šimurka, PhD., MUDr. Martin Matejka, PhD., MUDr. Jana Malinová
(2/2016, Review articles )
- STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - COMBINATION THERAPY FOR HYPERTENSION
Doc. MUDr. Milan Grundmann, CSc., MUDr. Ivana Kacířová
(2/2007, clearly )
- Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Safe and effective antihypertensive therapy in obesity
PharmDr. Iva Prokopová, Ph.D.
(4/2016, Clinical pharmacy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy )
- Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes )